A World Health Organization (WHO) expert panel countered concerns over the efficacy of the AstraZeneca COVID vaccine on Wednesday, insisting that “it’s
Governments and researchers have been working with an extremely ambitious timetable to provide billions of people with immunity to the new coronavirus. Now, the first vaccines are being distributed, spurring hope that the pandemic’s end is in sight.
MoreU.S. officials are considering a requirement for all travelers from Britain to offer proof they have tested negative for COVID-19.
MoreOn 14 December 2020, authorities of the United Kingdom (UK) reported to WHO that a new SARS-CoV-2 variant was identified through viral genomic sequencing.
MoreNearly two billion doses of COVID-19 vaccines have been secured for equitable distribution in 2021 to the 190 countries that have signed on to a World Health Organization-led partnership, according to a Friday announcement from the group.
MoreVice President Mike Pence received the Covid-19 vaccine in a televised appearance Friday morning in an effort to promote its safety and boost public confidence in its effectiveness.
MoreCOVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors
MoreEquitable distribution of COVID-19 vaccines will represent an “acid test” for the international community, the President of the UN Economic and Social Council (ECOSOC) told journalists on Wednesday, highlighting the importance of global cooperation and solidarity in beating back the disease.
MoreThe Food and Drug Administration recently granted emergency use authorization to a coronavirus vaccine from Pfizer, and approval for Moderna’s version is anticipated shortly.
MoreAs U.S. hospitals ramped up COVID-19 vaccinations Tuesday with the first vaccine approved for emergency use, federal regulators issued a favorable review of a second vaccine needed to combat the country's worsening crisis.
MoreFair and equitable access to a successful COVID-19 vaccine, regardless of income, for millions of people across Africa, Asia, the Caribbean and Pacific, and in Europe's eastern and southern neighbourhood, has been enabled by €500 million of new European financial support for the global vaccine initiative COVAX.
More